CN Patent

CN109906085B — 含有环孢素的眼用组合物

Assigned to Novaliq GmbH · Expires 2024-03-08 · 2y expired

What this patent protects

本发明涉及澄清溶液形式的组合物，其包含具有低残留含水量的环孢素和1‑全氟丁基‑戊烷。该组合物可用于局部施用于眼睛。

USPTO Abstract

本发明涉及澄清溶液形式的组合物，其包含具有低残留含水量的环孢素和1‑全氟丁基‑戊烷。该组合物可用于局部施用于眼睛。

Drugs covered by this patent

Sandimmune (cyclosporine) · Novartis AG (originally Sandoz)

Patent Metadata

Patent number: CN109906085B
Jurisdiction: CN
Classification: —
Expires: 2024-03-08
Drug substance claim: No
Drug product claim: No
Assignee: Novaliq GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.